Closing Plenary: Biomedical HIV Prevention Technologies. Are Our Systems Ready?


Closing Plenary: Biomedical HIV Prevention Technologies. Are Our Systems Ready?


TBA March 31, 2021 5:00 pm - 6:00 pm

Bookmark and Share


More than giving an update on the latest technologies, this plenary intends to ignite a community discussion on how accessible these technologies will be to the communities that need them the most. When PrEP was approved in 2012, it was seen as a paradigm shift in preventing HIV.

We went from condoms to pills, from behavioral counseling to medical visits. Nine years later, the uptake of PrEP continues to be significantly low among Black and Latino gay men compared with their white counterparts.

Health disparities get exacerbated with new technologies. If health care systems don’t prepare to deliver new modalities on HIV prevention, access to them will be limited to the privileged, worsening the health disparities that already exist.

Moderator:

Allysha C. Maragh-Bass, PhD

Allysha C. Maragh-Bass, PhD MPH
Scientist I, FHI 360
Adjunct Professor, Duke Global Health Institute
Visiting Assistant Professor, UCSF Center for AIDS Prevention Studies

Edwin Corbin-Gutierrez

Edwin Corbin-Gutierrez, Associate Director, Health Systems Integration, NASTAD, Washington, DC

Dr. Demetre C. Daskalakis, M.D., M.P.H.

Dr. Demetre C. Daskalakis, M.D., M.P.H. Director of the Division of HIV/ AIDS Prevention, Centers for Disease Control and Prevention

Latisia Grant, MPH

Latisia Grant, MPH, Senior Program Analyst, HIV, STI, & Viral Hepatitis, National Association of County and City Health Officials

Matthew Rose

Matthew Rose, Director of U.S. Policy and Advocacy Health, Global Access Project (GAP), Washington, DC